QLYS Form 4: Director John Zangardi Reports Sale of 3,860 Shares
Rhea-AI Filing Summary
John A. Zangardi, a director of Qualys, Inc. (QLYS), reported the sale of 3,860 shares of the issuer's common stock on 08/22/2025. The filing shows the sale code "S" with a weighted average sale price of $134.8197, and an indicated price range of $134.575 to $135.12 per share. After the reported transaction the filing lists 7,174 shares beneficially owned directly and an indirect holding of 5 shares attributed to his son. The Form 4 was signed by Bruce Posey by power of attorney on 08/25/2025. This report is a Section 16 disclosure of insider selling and provides the weighted average price range for the shares sold.
Positive
- Timely Section 16 disclosure of insider sale filed for transparency
- Sale price range disclosed (weighted average $134.8197; range $134.575–$135.12) allowing precise record
Negative
- Insider sold shares (3,860 shares), reducing direct ownership
- Filing provides no stated reason for the sale or indication of a Rule 10b5-1 plan
Insights
TL;DR: Director sale of 3,860 shares reported at a weighted average near $134.82; filing discloses post-sale holdings.
The Form 4 documents an insider sale rather than an acquisition, specifying 3,860 shares sold on 08/22/2025 at a weighted average price of $134.8197, with the sale prices ranging from $134.575 to $135.12. The reporting person remains a holder of 7,174 shares directly and 5 shares indirectly via a family member. This is a standard Section 16 disclosure that updates outstanding insider ownership; the filing does not provide rationale, scheduled plan information, or any derivative transactions.
TL;DR: Proper insider disclosure filed; sale executed and reported via a signed Form 4 with POA signature.
The Form 4 is completed to show compliance with Section 16 reporting obligations: the reporting person is identified as a director, the transaction date and sale details are provided, and the form bears a power-of-attorney signature dated 08/25/2025. The filing includes an explanatory note on the weighted average price band. There are no amendments or derivative security disclosures in this filing.